» Articles » PMID: 19114656

A Phosphorylation-dependent Intramolecular Interaction Regulates the Membrane Association and Activity of the Tumor Suppressor PTEN

Overview
Specialty Science
Date 2008 Dec 31
PMID 19114656
Citations 152
Authors
Affiliations
Soon will be listed here.
Abstract

The PI 3-phosphatase PTEN (phosphatase and tensin homologue deleted on chromosome 10), one of the most important tumor suppressors, must associate with the plasma membrane to maintain appropriate steady-state levels of phosphatidylinositol 3,4,5-triphosphate. Yet the mechanism of membrane binding has received little attention and the key determinants that regulate localization, a phosphatidylinositol 4,5-bisphosphate (PIP(2)) binding motif and a cluster of phosphorylated C-terminal residues, were not included in the crystal structure. We report that membrane binding requires PIP(2) and show that phosphorylation regulates an intramolecular interaction. A truncated version of the enzyme, PTEN(1-351), bound strongly to the membrane, an effect that was reversed by co-expression of the remainder of the molecule, PTEN(352-403). The separate fragments associated in vitro, an interaction dependent on phosphorylation of the C-terminal cluster, a portion of the PIP(2) binding motif, integrity of the phosphatase domain, and the CBR3 loop. Our investigation provides direct evidence for a model in which PTEN switches between open and closed states and phosphorylation favors the closed conformation, thereby regulating localization and function. Small molecules targeting these interactions could potentially serve as therapeutic agents in antagonizing Ras or PI3K-driven tumors. The study also stresses the importance of determining the structure of the native enzyme.

Citing Articles

Carbon Nanotube-Mediated Delivery of PTEN Variants: In Vitro Antitumor Activity in Breast Cancer Cells.

Papi R, Tasioulis K, Kechagioglou P, Papaioannou M, Andriotis E, Kyriakidis D Molecules. 2024; 29(12).

PMID: 38930850 PMC: 11206347. DOI: 10.3390/molecules29122785.


Actin-binding protein profilin1 is an important determinant of cellular phosphoinositide control.

Ricci M, Orenberg A, Ohayon L, Gau D, Wills R, Bae Y J Biol Chem. 2023; 300(1):105583.

PMID: 38141770 PMC: 10826164. DOI: 10.1016/j.jbc.2023.105583.


Regulatory mechanisms triggered by enzyme interactions with lipid membrane surfaces.

Yu J, Boehr D Front Mol Biosci. 2023; 10:1306483.

PMID: 38099197 PMC: 10720463. DOI: 10.3389/fmolb.2023.1306483.


Thrombomodulin Regulates PTEN/AKT Signaling Axis in Endothelial Cells.

Giri H, Biswas I, Rezaie A Arterioscler Thromb Vasc Biol. 2023; 44(2):352-365.

PMID: 38059351 PMC: 10841639. DOI: 10.1161/ATVBAHA.123.320000.


Cancer and Autism: How PTEN Mutations Degrade Function at the Membrane and Isoform Expression in the Human Brain.

Jang H, Chen J, Iakoucheva L, Nussinov R J Mol Biol. 2023; 435(24):168354.

PMID: 37935253 PMC: 10842829. DOI: 10.1016/j.jmb.2023.168354.


References
1.
Lee S, Yang K, Kwon J, Lee C, Jeong W, Rhee S . Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem. 2002; 277(23):20336-42. DOI: 10.1074/jbc.M111899200. View

2.
Denning G, Jean-Joseph B, Prince C, Durden D, Vogt P . A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth. Oncogene. 2007; 26(27):3930-40. DOI: 10.1038/sj.onc.1210175. View

3.
Vazquez F, Matsuoka S, Sellers W, Yanagida T, Ueda M, Devreotes P . Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane. Proc Natl Acad Sci U S A. 2006; 103(10):3633-8. PMC: 1450134. DOI: 10.1073/pnas.0510570103. View

4.
Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi P . Pten is essential for embryonic development and tumour suppression. Nat Genet. 1998; 19(4):348-55. DOI: 10.1038/1235. View

5.
Iijima M, Devreotes P . Tumor suppressor PTEN mediates sensing of chemoattractant gradients. Cell. 2002; 109(5):599-610. DOI: 10.1016/s0092-8674(02)00745-6. View